To strengthen the anabolic properties of testosterone, more than 100 synthetic steroid derivatives have been described for human purposes. The anabolic effect promotes protein synthesis, muscle growth and erythropoiesis. In clinical practice, substances with anabolic effect are needed to overcome various catabolic states. However, none of these compounds are devoid of androgenicity. Androgenic and anabolic properties of anabolic steroids cannot be totally separated. Therefore, it is more appropriate to use the term anabolic androgenic steroids (AAS).
Users on an oral steroid cycle may experience a sudden increase in body weight and muscular development, insomnia, irritability, aggressive combative behavior, puffy face, severe acne, bad breath, a yellowing of the eyes and skin, premature hair loss, hyperactivity, and exaggerated mood swings that include uncontrollable outbursts of anger. Males may also experience testicular shrinkage and can develop female breast tissue on the pectoral muscles. Females may also experience a deeper voice and decreased breast size. Continued use can result in life-threatening situations involving the liver, cardiovascular system, and brain.
Stanozolol is the generic name of stanozolol in English , German , French , and Japanese and its INN , USAN , USP , BAN , DCF , and JAN , while stanozololum is its name in Latin , stanozololo is its name in Italian and its DCIT , and estanozolol is its name in Spanish .    Androstanazole , stanazol , stanazolol , and estanazolol are unofficial synonyms of stanozolol.   The drug is also known generically by its former developmental code names NSC-43193 and WIN-14833 .